The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

U.S. consumers who have had their fill of finding protein added to everything from cereal to ice cream are about to meet the ...

Previous research has pointed to a link between ultraprocessed foods and colorectal cancer. For example, two studies from ...

The printing press helped build libraries that were impossibly large by ancient standards. That created its own new ...

As colon and rectal cancers in young people are on the rise globally, especially in the United States, consumption of ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

These foods make up 70% of the U.S. food supply and may be driving colon cancer rates in people under the age of 50, per the JAMA Oncology study.